CN115244049A - 一种用于治疗流感的药物组合物及含有该药物组合物的制剂 - Google Patents
一种用于治疗流感的药物组合物及含有该药物组合物的制剂 Download PDFInfo
- Publication number
- CN115244049A CN115244049A CN202180018914.9A CN202180018914A CN115244049A CN 115244049 A CN115244049 A CN 115244049A CN 202180018914 A CN202180018914 A CN 202180018914A CN 115244049 A CN115244049 A CN 115244049A
- Authority
- CN
- China
- Prior art keywords
- compound
- active ingredient
- pharmaceutical composition
- salt
- sha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本专利提供了一种药物组合物，该药物组合物包含第一有效成分和第二有效成分及可选择有或无的第三有效成分，各有效成分之间具有较好的药物协同作用，综合评价后认为具有较好的成药前景。
Description
PCT国内申请，说明书已公开。
Claims (30)
- PCT国内申请，权利要求书已公开。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010150025 | 2020-03-06 | ||
| CN2020101500255 | 2020-03-06 | ||
| PCT/CN2021/078389 WO2021175173A1 (zh) | 2020-03-06 | 2021-03-01 | 一种用于治疗流感的药物组合物及含有该药物组合物的制剂 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115244049A true CN115244049A (zh) | 2022-10-25 |
Family
ID=76772310
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202180018914.9A Pending CN115244049A (zh) | 2020-03-06 | 2021-03-01 | 一种用于治疗流感的药物组合物及含有该药物组合物的制剂 |
| CN202110224097.4A Active CN113116899B (zh) | 2020-03-06 | 2021-03-01 | 一种用于治疗流感的药物组合物及含有该药物组合物的制剂 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110224097.4A Active CN113116899B (zh) | 2020-03-06 | 2021-03-01 | 一种用于治疗流感的药物组合物及含有该药物组合物的制剂 |
Country Status (2)
| Country | Link |
|---|---|
| CN (2) | CN115244049A (zh) |
| WO (1) | WO2021175173A1 (zh) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101569700B (zh) * | 2009-05-05 | 2010-12-15 | 广东众生药业股份有限公司 | 一种中药药物在制备治疗人患禽流行性感冒药物中的应用 |
| CR20180356A (es) * | 2015-12-15 | 2018-08-22 | Shionogi & Co | Un medicamento caracterizado por combinar un inhibidor de la endonucleasa cap-dependiente del virus de la influenza y un fármaco anti-influenza |
| CN107759571B (zh) * | 2016-08-16 | 2021-03-02 | 广东东阳光药业有限公司 | 流感病毒复制抑制剂及其使用方法和用途 |
| CN109641868B (zh) * | 2016-08-30 | 2021-12-03 | 广东东阳光药业有限公司 | 流感病毒复制抑制剂及其使用方法和用途 |
| JP6838773B2 (ja) * | 2016-09-05 | 2021-03-03 | 広東衆生睿創生物科技有限公司Ｇｕａｎｇｄｏｎｇ Ｒａｙｎｏｖｅｎｔ Ｂｉｏｔｅｃｈ Ｃｏ．，Ｌｔｄ． | 抗インフルエンザウイルスのピリミジニル誘導体 |
| SG11202011447UA (en) * | 2018-01-17 | 2020-12-30 | Jiangxi Caishi Pharmaceutical Technology Co Ltd | Pyridone derivative, composition and use as antiviral drug thereof |
| US11535613B2 (en) * | 2018-03-05 | 2022-12-27 | Guangdong Raynovent Biotech Co., Ltd. | Crystal form and salt form of pyridoimidazole compound and preparation method therefor |
| US20190298669A1 (en) * | 2018-03-29 | 2019-10-03 | Atriva Therapeutics Gmbh | Ci-1040 for the treatment of viral diseases |
-
2021
- 2021-03-01 CN CN202180018914.9A patent/CN115244049A/zh active Pending
- 2021-03-01 CN CN202110224097.4A patent/CN113116899B/zh active Active
- 2021-03-01 WO PCT/CN2021/078389 patent/WO2021175173A1/zh active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021175173A1 (zh) | 2021-09-10 |
| CN113116899B (zh) | 2022-12-20 |
| CN113116899A (zh) | 2021-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1935892B1 (en) | Glycyrrhetinic acid-30-amide derivatives and the uses thereof | |
| JP4816828B2 (ja) | ソリフェナシン非晶質体を含有した固形医薬組成物 | |
| TWI579277B (zh) | 取代桂皮醯胺衍生物、其製備方法、其應用及醫藥組成物 | |
| KR20140082858A (ko) | Ｈｉｖ 인테그라제 억제제의 약동학을 개선하기 위한 방법 | |
| CN104379130A (zh) | 曲尼司特组合物和共结晶体 | |
| CN103313982B (zh) | 苯基-异噁唑衍生物及其制备方法 | |
| KR101902567B1 (ko) | 플루오로치환된 (3r,4r,5s)-5-구아니디노-4-아세트아미도-3-(펜탄-3-일옥시)사이클로헥센-1-카복실릭 엑시드, 이의 에스테르 및 이의 용도 | |
| KR20220016105A (ko) | 통풍 또는 고요산혈증을 치료하기 위한 화합물 | |
| TW202011965A (zh) | 嗜中性球彈性蛋白酶抑制劑在肝病中之用途 | |
| CN112409379A (zh) | 氘代的二氢二苯并硫杂卓化合物以及包含该化合物的药物组合物 | |
| WO2020183227A1 (en) | Treating influenza using substituted polycyclic pyridone derivatives and prodrugs thereof in a subject having influenza and a complication risk factor | |
| CN114502150B (zh) | 一种用于治疗病毒性感冒的药物组合物及其制剂 | |
| WO2013091704A1 (en) | Pharmaceutical composition comprising fingolimod | |
| CN113116899B (zh) | 一种用于治疗流感的药物组合物及含有该药物组合物的制剂 | |
| CN104940160A (zh) | 改进的磷酸奥司他韦固体组合物及其制备方法 | |
| CN111544431A (zh) | 硝唑尼特在制备预防及治疗间质性肺病药物中的应用 | |
| CA2649090A1 (en) | Intramuscular antiviral treatments | |
| CN111012770B (zh) | 单碘代苯甲酸类化合物及其在抗adv7病毒中的应用 | |
| KR20200086257A (ko) | 감각 모 세포 사멸 예방 또는 치료용 화합물의 결정질 형태 | |
| US20080118555A1 (en) | Stable pharmaceutical composition containing desloratadine | |
| CN107344920A (zh) | 一种帕拉米韦倍半水合物化合物 | |
| US20230151034A1 (en) | Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication | |
| EP2996681B1 (en) | Pharmaceutical composition comprising fingolimod | |
| TW202114678A (zh) | 氮雜吲哚化合物之調配物 | |
| CN113546067A (zh) | 具有抗病毒作用的蒽醌衍生物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |